The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PIK3CA mutations in primary HER2-positive and triple negative breast cancer.
Sibylle Loibl
No relevant relationships to disclose
Carsten Denkert
No relevant relationships to disclose
Sherene Loi
No relevant relationships to disclose
Fabrice Andre
No relevant relationships to disclose
Berit Mueller
No relevant relationships to disclose
Andreas Schneeweiss
No relevant relationships to disclose
Jens U. Blohmer
No relevant relationships to disclose
Christian Jackisch
No relevant relationships to disclose
Guo Sanxing
No relevant relationships to disclose
Stephan Gade
No relevant relationships to disclose
Peter A. Fasching
No relevant relationships to disclose
Christian Schem
No relevant relationships to disclose
Christos Sotiriou
No relevant relationships to disclose
Michael Untch
No relevant relationships to disclose
Gunter Von Minckwitz
No relevant relationships to disclose